Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections.
Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Plaisance KI, et al. Among authors: wasserman ss. Pharmacotherapy. 2000 Dec;20(12):1417-22. doi: 10.1592/phco.20.19.1417.34865. Pharmacotherapy. 2000. PMID: 11130213
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.
Kotloff KL, Wasserman SS, O'Donnell S, Losonsky GA, Cryz SJ, Levine MM. Kotloff KL, et al. Among authors: wasserman ss. Infect Immun. 1992 Oct;60(10):4430-2. doi: 10.1128/IAI.60.10.4430-4432.1992. Infect Immun. 1992. PMID: 1398956 Free PMC article. Clinical Trial.
An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis.
Mackowiak PA, Wasserman SS, Levine MM. Mackowiak PA, et al. Among authors: wasserman ss. J Infect Dis. 1992 Nov;166(5):1181-4. doi: 10.1093/infdis/166.5.1181. J Infect Dis. 1992. PMID: 1402032
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Van de Verg L, Herrington DA, Murphy JR, Wasserman SS, Formal SB, Levine MM. Van de Verg L, et al. Among authors: wasserman ss. Infect Immun. 1990 Jun;58(6):2002-4. doi: 10.1128/IAI.58.6.2002-2004.1990. Infect Immun. 1990. PMID: 1692813 Free PMC article.
Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB, Wasserman SS, Glass RI, Keane VA. Rennels MB, et al. Among authors: wasserman ss. Pediatrics. 1995 Dec;96(6):1132-6. Pediatrics. 1995. PMID: 7491235 Clinical Trial.
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: wasserman ss. Vaccine. 1995 Apr;13(5):495-502. doi: 10.1016/0264-410x(94)00011-b. Vaccine. 1995. PMID: 7639017 Clinical Trial.
Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines.
Mackowiak PA, Wasserman SS, Tacket CO, Vaughn DW, Eckels KH, Dubois DR, Hoke CH, Edelman R. Mackowiak PA, et al. Among authors: wasserman ss. Clin Infect Dis. 1994 Nov;19(5):948-50. doi: 10.1093/clinids/19.5.948. Clin Infect Dis. 1994. PMID: 7893886
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.
Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH. Edelman R, et al. Among authors: wasserman ss. J Infect Dis. 1994 Dec;170(6):1448-55. doi: 10.1093/infdis/170.6.1448. J Infect Dis. 1994. PMID: 7995984 Clinical Trial.
Relationship between humoral immune responses and oral temperature during human shigellosis.
Mackowiak PA, Wasserman SS, Levine MM. Mackowiak PA, et al. Among authors: wasserman ss. J Infect Dis. 1993 Jun;167(6):1449-52. doi: 10.1093/infdis/167.6.1449. J Infect Dis. 1993. PMID: 8501337
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.
Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, Taylor DN, Sadoff JC, Levine MM. Kotloff KL, et al. Among authors: wasserman ss. Vaccine. 1995 Nov;13(16):1488-94. doi: 10.1016/0264-410x(95)00102-7. Vaccine. 1995. PMID: 8578831 Clinical Trial.
98 results
Jump to page
Feedback